Brain, Vol. 117, No. 2, 317-323, 1994
© 1994 Oxford University Press
research-article |
Motor cortical inhibition and the dopaminergic system
Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism
Dipartimento Scienze Neurologiche, Universita' degli Studi di Roma, ‘La Sapienza’, Viale Universita' 30 00185 Roma, Italia
Correspondence to:
Alfredo Berardelli MD, Dipartimento Scienze Neurologiche, Viale Universita' 30, 00185 Roma, Italia
The silent period after contralateral and ipsilateral transcranial magnetic brain stimulation was studied in patients with Parkinson's disease before and after dopaminergic and anticholinergic therapy; in normal subjects before and after L-dopa administration and in patients with drug-induced parkinsonism. In patients and normal subjects the silent period was also studied after peripheral nerve stimulation. The silent period after transcranial cortical stimulation was shorter in Parkinson's disease patients than in normal subjects. In patients with Parkinson's disease L-dopa prolonged the silent period after transcranial brain stimulation and after ipsilateral cortical stimulation. Biperiden prolonged the silent period after transcranial brain stimulation. In normal subjects, L-dopa produced similar but smaller changes. In the patients with druginduced parkinsonism the silent period after transcranial magnetic stimulation was shorter than normal subjects. The peripheral silent period was similar in normal subjects and in patients and did not change after drug administration. In conclusion cortical silent period is abnormal in patients with Parkinson' s disease and drug-induced parkinsonism. Dopaminergic drugs modulate the duration of the cortical silent periods in patients and in normal subjects, through mechanisms acting mainly at basal ganglia and possibly also directly at cortical level.
cortical stimulation; motor cortex; Parkinson's disease; dopaminergic system; neuroleptic drugs
Received August 12, 1993. Revised November 18, 1993. Accepted December 21, 1993.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Chu, A. Wagle-Shukla, C. Gunraj, A. E. Lang, and R. Chen Impaired presynaptic inhibition in the motor cortex in Parkinson disease Neurology, March 3, 2009; 72(9): 842 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Dashtipour, M. Barahimi, and S. Karkar Cervical Dystonia Journal of Pharmacy Practice, December 1, 2007; 20(6): 449 - 457. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. Ni, C. Gunraj, and R. Chen Short interval intracortical inhibition and facilitation during the silent period in human J. Physiol., September 15, 2007; 583(3): 971 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Todd, J. L. Taylor, J. E. Butler, P. G. Martin, R. B. Gorman, and S. C. Gandevia Use of motor cortex stimulation to measure simultaneously the changes in dynamic muscle properties and voluntary activation in human muscles J Appl Physiol, May 1, 2007; 102(5): 1756 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Grafton, R. S. Turner, M. Desmurget, R. Bakay, M. Delong, J. Vitek, and M. Crutcher Normalizing motor-related brain activity: Subthalamic nucleus stimulation in Parkinson disease Neurology, April 25, 2006; 66(8): 1192 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. -Z. Huang, I. Trender-Gerhard, M. J. Edwards, P. Mir, J. C. Rothwell, and K. P. Bhatia Motor system inhibition in dopa-responsive dystonia and its modulation by treatment Neurology, April 11, 2006; 66(7): 1088 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Morgante, A. J. Espay, C. Gunraj, A. E. Lang, and R. Chen Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias Brain, April 1, 2006; 129(4): 1059 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mir, K. Matsunaga, F. Gilio, N. P. Quinn, H. R. Siebner, and J. C. Rothwell Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease Neurology, June 14, 2005; 64(11): 1906 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Payoux, P. Remy, P. Damier, M. Miloudi, I. Loubinoux, B. Pidoux, V. Gaura, O. Rascol, Y. Samson, and Y. Agid Subthalamic Nucleus Stimulation Reduces Abnormal Motor Cortical Overactivity in Parkinson Disease Arch Neurol, August 1, 2004; 61(8): 1307 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Andersen, B. Westlund, and C. Krarup Failure of activation of spinal motoneurones after muscle fatigue in healthy subjects studied by transcranial magnetic stimulation J. Physiol., August 15, 2003; 551(1): 345 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L Pearce, T. S Miles, P. D Thompson, and M. A Nordstrom Responses of single motor units in human masseter to transcranial magnetic stimulation of either hemisphere J. Physiol., June 1, 2003; 549(2): 583 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Curra, N. Modugno, M. Inghilleri, M. Manfredi, M. Hallett, and A. Berardelli Transcranial magnetic stimulation techniques in clinical investigation Neurology, December 24, 2002; 59(12): 1851 - 1859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dauper, T. Peschel, C. Schrader, C. Kohlmetz, G. Joppich, W. Nager, R. Dengler, and J. D. Rollnik Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability Neurology, September 10, 2002; 59(5): 700 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Cunic, L. Roshan, F. I. Khan, A. M. Lozano, A. E. Lang, and R. Chen Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease Neurology, June 11, 2002; 58(11): 1665 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gironell, J. Kulisevsky, B. P. Sedano, J. Molet, R. Chen, R. R. Garg, A. M. Lozano, and A. E. Lang Effects of internal globus pallidus stimulation on motor cortex excitability Neurology, February 26, 2002; 58(4): 669 - 670. [Full Text] [PDF]
|
|
|
|
|
|
A. Berardelli, J. C. Rothwell, P. D. Thompson, and M. Hallett Pathophysiology of bradykinesia in Parkinson's disease Brain, November 1, 2001; 124(11): 2131 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A V Chistyakov, J F Soustiel, H Hafner, M Trubnik, G Levy, and M Feinsod Excitatory and inhibitory corticospinal responses to transcranial magnetic stimulation in patients with minor to moderate head injury J. Neurol. Neurosurg. Psychiatry, May 1, 2001; 70(5): 580 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chen, R. R. Garg, A. M. Lozano, and A. E. Lang Effects of internal globus pallidus stimulation on motor cortex excitability Neurology, March 27, 2001; 56(6): 716 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D Sanger, R. R Garg, and R. Chen Interactions between two different inhibitory systems in the human motor cortex J. Physiol., January 15, 2001; 530(2): 307 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Meunier, S. Pol, J. L. Houeto, and M. Vidailhet Abnormal reciprocal inhibition between antagonist muscles in Parkinson's disease Brain, May 1, 2000; 123(5): 1017 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Entezari-Taher, J. R. Singleton, C. R. Jones, G. Meekins, J. H. Petajan, and A. G. Smith Changes in excitability of motor cortical circuitry in primary restless legs syndrome Neurology, October 1, 1999; 53(6): 1201 - 1201. [Abstract] [Full Text]
|
|
|
|
|
|
N. J Davey, B. K Puri, H. S Lewis, S. W Lewis, and P. H Ellaway Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia J. Neurol. Neurosurg. Psychiatry, October 1, 1997; 63(4): 468 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Friedman Neurobiology of Cholesterol and Violent Behavior Arch Intern Med, March 13, 1995; 155(5): 543 - 544. [Abstract] [PDF]
|
|